Leah Monteiro Email

VP, Investor Relations and Communications . Solid Biosciences

Current Roles

Employees:
110
Revenue:
$10.5M
About
Solid Biosciences (Solid) is a Cambridge, MA based biotech company singularly focused on developing treatments and cures for Duchenne muscular dystrophy (DMD). Solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. Condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of DMD.
Solid Biosciences Address
500 Rutherford Avenue
Cambridge, MA
United States

Past Companies

Solid BiosciencesVP, Investor Relations and Communications
Magenta TherapeuticsVice President, Investor Relations
KalVista Pharmaceuticals, Inc.Senior Director, Corporate Communications and Investor Relations

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.